Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

SRx Health Solutions (SRXH) EBIT (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed EBIT for 16 consecutive years, with -$17.4 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, EBIT fell 1217.85% year-over-year to -$17.4 million, compared with a TTM value of -$10.5 million through Jun 2025, up 44.95%, and an annual FY2024 reading of $4.2 million, up 119.79% over the prior year.
  • EBIT was -$17.4 million for Q2 2025 at SRx Health Solutions, down from -$1.1 million in the prior quarter.
  • Across five years, EBIT topped out at $22.9 million in Q4 2022 and bottomed at -$17.4 million in Q2 2025.
  • Average EBIT over 5 years is -$2.5 million, with a median of -$3.2 million recorded in 2021.
  • The sharpest move saw EBIT surged 559.84% in 2022, then crashed 1217.85% in 2025.
  • Year by year, EBIT stood at -$5.0 million in 2021, then soared by 559.84% to $22.9 million in 2022, then plummeted by 155.59% to -$12.7 million in 2023, then skyrocketed by 171.58% to $9.1 million in 2024, then plummeted by 291.3% to -$17.4 million in 2025.
  • Business Quant data shows EBIT for SRXH at -$17.4 million in Q2 2025, -$1.1 million in Q1 2025, and $9.1 million in Q4 2024.